Corvus Pharmaceuticals
CRVS
CRVS
61 hedge funds and large institutions have $219M invested in Corvus Pharmaceuticals in 2018 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 26 increasing their positions, 14 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
1.06% less ownership
Funds ownership: 88.75% → 87.69% (-1.1%)
21% less capital invested
Capital invested by funds: $279M → $219M (-$59.1M)
Holders
61
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$894K | |
| 2 | +$746K | |
| 3 | +$618K | |
| 4 |
CI
Cowen Inc
New York
|
+$466K |
| 5 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
+$376K |
Top Sellers
| 1 | -$3.94M | |
| 2 | -$2.65M | |
| 3 | -$849K | |
| 4 |
Goldman Sachs
New York
|
-$335K |
| 5 |
Manulife (Manufacturers Life Insurance)
Canada,
Ontario, Canada
|
-$135K |